Entactogens: Why MDMA Is Not a Classic Psychedelic
What entactogens (or empathogens) are, why MDMA is grouped apart from classic psychedelics, and what sources say about its action, risks and research status.
Content last updated . This page has not been medically reviewed.
What the word means
"Entactogen" and "empathogen" are words that stress the social and emotional side of an experience, in the same way that "entheogen" stresses the spiritual side and "hallucinogen" the perceptual side. [1] An early scientific paper by David Nichols (1986) is titled "Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens." [2] MDMA is the main example.What MDMA is
MDMA (3,4-methylenedioxymethamphetamine) is described by the US National Institute on Drug Abuse (NIDA) as a lab-made, synthetic drug with effects similar to stimulants such as methamphetamine. NIDA adds that some researchers and organizations consider it a psychedelic because it can also mildly alter visual and time perception. [3] So the classification is discussed, but the way the drug works is what separates it from the classic group.How it differs from classic psychedelics
| Classic psychedelics | MDMA | |
|---|---|---|
| Origin | Varies: fungus, cactus, plant compound, semisynthetic | Lab-made (synthetic) [3] |
| Main action described by NIDA | Mainly act on serotonin 5-HT2A receptors | Stimulates release of serotonin and weakly activates serotonin receptors; also increases dopamine and norepinephrine activity [4] |
| Where NIDA places it | Psychedelic group | "Other" group |
[4]
The FDA's 2026 guidance on clinical trials of psychedelic drugs shows how regulators handle this. It uses "psychedelic drug" as shorthand covering two sets: classic psychedelics, typically understood to be 5-HT2A receptor agonists such as psilocybin and LSD, and, separately, entactogens or empathogens such as MDMA. [5] FDA adds that its concepts may also apply to other related products that can cause perceptual disturbances and alterations in consciousness. [5] That is a regulatory shorthand for one guidance document, not a statement that the two sets act the same way. See also MDMA vs Classic Psychedelics and Classic Psychedelics.
Risks documented by NIDA
- Higher blood pressure, jaw clenching, nausea and vomiting. People can also experience a dangerously steep rise in body temperature (hyperpyrexia), particularly if very physically active or in a warm environment. [3]
- Using MDMA with alcohol or some prescription drugs, including selective serotonin reuptake inhibitors (SSRIs), may increase the risk of negative health effects. [3]
- Drugs sold as MDMA can contain other substances that the buyer does not know about. [3]
- Limited research suggests MDMA may be associated with mild or moderate heart valve disease. [4]
Research and approval status
Insufficient evidence for general use; under study as a clinical product. According to NIDA's page read 2026-10-22, researchers are studying MDMA-assisted therapy for severe PTSD, FDA designated MDMA a breakthrough therapy to expedite research for PTSD, and only esketamine is FDA approved for therapeutic use to date. [6] A breakthrough designation is not an approval. The evidence for PTSD is covered in PTSD Research and the compound is profiled in MDMA: Compound Guide.Legal context (United States, federal only)
MDMA is named in the list of hallucinogenic substances in Schedule I of the US Controlled Substances Act regulations (21 CFR 1308.11(d)); the list was read on the eCFR site on 2026-10-22. [7] Laws differ by country and by state, they change, and this is not legal advice. See Psychedelic Legal Status.Evidence labels used
Approved medicine names what a regulator has approved. Insufficient evidence means studies are not yet enough to say whether a use works and is safe. Nothing on this page is evidence that MDMA is a treatment.Education only
This page explains a category and documented risks. It gives no amounts, sourcing advice or advice to use or combine anything.Frequently asked questions
Is MDMA a classic psychedelic?
No. NIDA puts it in an "other" group because it mainly releases serotonin and affects other messengers rather than mainly acting on 5-HT2A receptors. [4] Some researchers do consider it psychedelic because it mildly alters perception. [3]
What is an empathogen?
A word used for substances whose reported effects are social and emotional. It is often used interchangeably with entactogen. [1]
Is MDMA a stimulant?
NIDA describes MDMA as having effects similar to stimulants like methamphetamine. [3]
Is MDMA approved to treat PTSD?
Not according to NIDA's page read 2026-10-22: it describes MDMA-assisted therapy for PTSD as under study with a breakthrough therapy designation. [6]
Why does the FDA group MDMA with psychedelics?
In its clinical-trial guidance FDA uses "psychedelic drug" as shorthand for classic psychedelics plus entactogens such as MDMA. That is a convenience for one regulatory document, and the guidance itself keeps the two sets distinct. [5]
References
- Kelmendi B et al. Psychedelics. Curr Biol. 2022;32(2):R63-R67. Read 2026-10-22 (abstract on PubMed).
- Nichols DE. Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens. J Psychoactive Drugs. 1986;18(4):305-13. Read 2026-10-22 (PubMed record, title only; no abstract).
- National Institute on Drug Abuse, MDMA (Ecstasy/Molly). Read 2026-10-22.
- National Institute on Drug Abuse, Psychedelic and Dissociative Drugs. Read 2026-10-22.
- US Food and Drug Administration, Psychedelic Drugs: Considerations for Clinical Investigations, Guidance for Industry (July 2026). Read 2026-10-22.
- National Institute on Drug Abuse, Psychedelic and Dissociative Drugs as Medicines. Read 2026-10-22.
- US Electronic Code of Federal Regulations, 21 CFR 1308.11 Schedule I. Read 2026-10-22.